{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T17:47:36Z","timestamp":1759600056192,"version":"3.40.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T00:00:00Z","timestamp":1372291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10557-013-6473-x","type":"journal-article","created":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T07:24:41Z","timestamp":1372231481000},"page":"393-402","source":"Crossref","is-referenced-by-count":14,"title":["Angiotensin II Type 2 Receptor (AT2R) is Associated with Increased Tolerance of the Hyperthyroid Heart to Ischemia-Reperfusion"],"prefix":"10.1007","volume":"27","author":[{"given":"Felix Meira","family":"Tavares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivson Bezerra","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayane Aparecida","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza Morais","family":"Barreto-Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,27]]},"reference":[{"key":"6473_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10741-008-9125-7","volume":"15","author":"W Dillmann","year":"2010","unstructured":"Dillmann W. Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev. 2010;15:125\u201332.","journal-title":"Heart Fail Rev."},{"key":"6473_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/rp.59.1.31","volume":"59","author":"S Fazio","year":"2004","unstructured":"Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res. 2004;59:31\u201350.","journal-title":"Recent Prog Horm Res."},{"key":"6473_CR3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","volume":"26","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly GJ, Dillmann WH. Tyroid hormone action in the heart. Endocr Rev. 2005;26:704\u201328.","journal-title":"Endocr Rev"},{"key":"6473_CR4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/01.RES.88.3.260","volume":"88","author":"I Klein","year":"2001","unstructured":"Klein I, Ojamaa K. Thyroid hormone: targeting the vascular smooth muscle cell. Circ Res. 2001;88:260\u20131.","journal-title":"Circ Res"},{"key":"6473_CR5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/01.RES.66.3.735","volume":"66","author":"PT Buser","year":"1990","unstructured":"Buser PT, Wikman-Coffelt J, Wu ST, Derugin N, Parmley WW, Higgins CB. Postischaemic recovery of mechanical performance and energy metabolism in the presence of left ventricular hypertrophy. A 31P-MRS study. Circ Res. 1990;66:735\u201346.","journal-title":"Circ Res"},{"key":"6473_CR6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00005344-200009000-00015","volume":"36","author":"C Pantos","year":"2000","unstructured":"Pantos C, Mourouzis I, Tzeis S, et al. Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischaemic contracture in hyperthyroid hearts. J Cardiovasc Pharmacol. 2000;36:384\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6473_CR7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0024-3205(99)00641-4","volume":"66","author":"P Venditti","year":"2000","unstructured":"Venditti P, Masullo P, Agnisola C, Di Meo S. Effect of vitamin E on the response to ischaemia-reperfusion of Langendorff heart preparations from hyperthyroid rats. Life Sci. 2000;66:697\u2013708.","journal-title":"Life Sci"},{"key":"6473_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/10507250252949469","volume":"12","author":"C Pantos","year":"2002","unstructured":"Pantos C, Malliopoulou V, Mourouzis I, et al. Long-term thyroxine administration protects the heart in a similar pattern as ischaemic preconditioning. Thyroid. 2002;12:325\u20139.","journal-title":"Thyroid"},{"key":"6473_CR9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1021162417490","volume":"242","author":"C Pantos","year":"2003","unstructured":"Pantos C, Malliopoulou V, Paizis I, et al. Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart. Mol Cell Biochem. 2003;242:173\u201380.","journal-title":"Mol Cell Biochem"},{"key":"6473_CR10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ejcts.2004.07.003","volume":"26","author":"M Sirlak","year":"2004","unstructured":"Sirlak M, Yazicoglu L, Inan MB, et al. Oral thyroid hormone pretreatment in left ventricular dysfunction. Eur J Cardiothorac Surg. 2004;26:720\u20135.","journal-title":"Eur J Cardiothorac Surg"},{"key":"6473_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00395-003-0449-0","volume":"99","author":"C Pantos","year":"2004","unstructured":"Pantos C, Malliopoulou V, Varonos DD, Cokkinos DV. Thyroid hormone and phenotypes of cardioprotection. Basic Res Cardiol. 2004;99:101\u201320.","journal-title":"Basic Res Cardiol."},{"key":"6473_CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.vph.2009.10.009","volume":"52","author":"ML Barreto-Chaves","year":"2010","unstructured":"Barreto-Chaves ML, Carrillo-Sep\u00falveda MA, Carneiro-Ramos MS, Gomes DA, Diniz GP. The crosstalk between thyroid hormones and the renin-angiotensin system. Vascul Pharmacol. 2010;52:166\u201370.","journal-title":"Vascul Pharmacol."},{"key":"6473_CR13","doi-asserted-by":"crossref","first-page":"R1473","DOI":"10.1152\/ajpregu.00269.2003","volume":"285","author":"LW Hu","year":"2003","unstructured":"Hu LW, Benvenutti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaves ML. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol. 2003;285:R1473\u201380.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"6473_CR14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00395-009-0043-1","volume":"104","author":"GP Diniz","year":"2009","unstructured":"Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt\/GSK-3beta\/mTOR signaling pathway. Basic Res Cardiol. 2009;104:653\u201367.","journal-title":"Basic Res Cardiol."},{"key":"6473_CR15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00395-010-0089-0","volume":"105","author":"MS Carneiro-Ramos","year":"2010","unstructured":"Carneiro-Ramos MS, Diniz GP, Nadu AP, et al. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res Cardiol. 2010;105:325\u201335.","journal-title":"Basic Res Cardiol"},{"key":"6473_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","volume":"52","author":"M Gasparato De","year":"2000","unstructured":"De Gasparato M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52:415\u201372.","journal-title":"Pharmacol Rev"},{"key":"6473_CR17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-201X.2004.01322.x","volume":"181","author":"V Gross","year":"2004","unstructured":"Gross V, Obst M, Luft FC. Insights into angiotensin II receptor function through AT2 receptor knockout mice. Acta Physiol Scand. 2004;181:487\u201394.","journal-title":"Acta Physiol Scand."},{"key":"6473_CR18","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/01.hjh.0000388495.66330.63","volume":"28","author":"UM Steckelings","year":"2010","unstructured":"Steckelings UM, Widdop RE, Paulis L, Unger T. The angiotensin AT2 receptor in left ventricular hypertrophy. J Hypertens. 2010;28:S50\u20135.","journal-title":"J Hypertens"},{"key":"6473_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-8703(94)90002-7","volume":"128","author":"M Yoshiyama","year":"1994","unstructured":"Yoshiyama M, Kim S, Yamagishi H, et al. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury. Am Heart J. 1994;128:1\u20136.","journal-title":"Am Heart J"},{"key":"6473_CR20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.RES.83.5.552","volume":"83","author":"BC Yang","year":"1998","unstructured":"Yang BC, Phillips MI, Zhang YC, et al. Critical role of AT1 receptor expression after ischemia\/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA. Circ Res. 1998;83:552\u20139.","journal-title":"Circ Res"},{"key":"6473_CR21","doi-asserted-by":"crossref","first-page":"H1206","DOI":"10.1152\/ajpheart.00839.2000","volume":"282","author":"Y Xu","year":"2002","unstructured":"Xu Y, Kumar D, Dyck JR, Ford WR, Clanachan AS, Lopaschuk GD, et al. AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts. Am J Physiol Heart Circ Physiol. 2002;282:H1206\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Suppl 1","key":"6473_CR22","first-page":"139","volume":"88","author":"K Przyklenk","year":"1993","unstructured":"Przyklenk K, Kloner RA. \u201cCardioprotection\u201d by ACE-inhibitors in acute myocardial ischemia and infarction? Basic Res Cardiol. 1993;88 Suppl 1:139\u201354.","journal-title":"Basic Res Cardiol."},{"key":"6473_CR23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-2005-870317","volume":"37","author":"C Pantos","year":"2005","unstructured":"Pantos C, Paizis I, Mourouzis I, et al. Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning. Horm Metab Res. 2005;37:500\u20134.","journal-title":"Horm Metab Res"},{"key":"6473_CR24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01812150","volume":"61","author":"O Langendorff","year":"1895","unstructured":"Langendorff O. Untersuchungen an uberlebenden Saugethierherzen. Pfl\u00fcgers Arch. 1895;61:291\u2013332.","journal-title":"Pfl\u00fcgers Arch"},{"key":"6473_CR25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1152\/jappl.1967.22.4.836","volume":"22","author":"EL Fallen","year":"1967","unstructured":"Fallen EL, Elliot WC, Gorlin R. Apparatus for study of ventricular function and metabolism in the isolated perfused rat heart. J Appl Physiol. 1967;22:836\u20139.","journal-title":"J Appl Physiol"},{"key":"6473_CR26","doi-asserted-by":"crossref","first-page":"e61982","DOI":"10.1371\/journal.pone.0061982","volume":"8","author":"MA Carrillo-Sepulveda","year":"2013","unstructured":"Carrillo-Sepulveda MA, Ceravolo GS, Furstenau CR, et al. Emerging role of angiotensin type 2 receptor (AT2R) \/Akt\/ NO pathway in vascular smooth muscle cell in the hyperthyroidism. PLoS One. 2013;8:e61982.","journal-title":"PLoS One"},{"key":"6473_CR27","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI119360","volume":"9","author":"YH Liu","year":"1997","unstructured":"Liu YH, Yang XP, Sharov VG, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest. 1997;9:1926\u201335.","journal-title":"J Clin Invest"},{"key":"6473_CR28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354.","journal-title":"Anal Biochem"},{"key":"6473_CR29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1113\/expphysiol.2012.067066","volume":"97","author":"LH Opie","year":"2012","unstructured":"Opie LH. Cardioprotection at a distance\u2014remote conditioning takes the stage. Exp Physiol. 2012;97:905.","journal-title":"Exp Physiol"},{"key":"6473_CR30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1055\/s-2006-925404","volume":"38","author":"C Pantos","year":"2006","unstructured":"Pantos C, Malliopoulou V, Mourouzis I, et al. Hyperthyroid hearts display a phenotype of cardioprotection against ischemic stress: a possible involvement of heat shock protein 70. Horm Metab Res. 2006;38:308\u201313.","journal-title":"Horm Metab Res"},{"key":"6473_CR31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MED.0b013e32834a785c","volume":"18","author":"ML Barreto-Chaves","year":"2011","unstructured":"Barreto-Chaves ML, de Souza MP, F\u00fcrstenau CR. Acute actions of thyroid hormone on blood vessel biochemistry and physiology. Curr Opin Endocrinol Diabetes Obes. 2011;18:300\u20133.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"6473_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00424-006-0192-0","volume":"454","author":"GP Diniz","year":"2007","unstructured":"Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML. Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-B1 in thyroid hormone-induced cardiac hypertrophy. Pflugers Arch - Eur J Physiol. 2007;454:75\u201381.","journal-title":"Pflugers Arch - Eur J Physiol."},{"key":"6473_CR33","doi-asserted-by":"crossref","first-page":"236S","DOI":"10.1093\/ajh\/5.12.236S","volume":"5","author":"TJ Murphy","year":"1992","unstructured":"Murphy TJ, Takeuchi K, Alexander RW. Molecular cloning of AT1 angiotensin receptors. Am J Hypertens. 1992;5:236S\u201342.","journal-title":"Am J Hypertens"},{"key":"6473_CR34","doi-asserted-by":"crossref","first-page":"24543","DOI":"10.1016\/S0021-9258(19)74499-8","volume":"268","author":"Y Kambayashi","year":"1993","unstructured":"Kambayashi Y, Bardhan S, Takahashi K, et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 1993;268:24543\u20136.","journal-title":"J Biol Chem"},{"key":"6473_CR35","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1172\/JCI118630","volume":"97","author":"HM Siragy","year":"1996","unstructured":"Siragy HM, Carey RM. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3\u2032, 5\u2032-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest. 1996;97:1978\u201382.","journal-title":"J Clin Invest"},{"key":"6473_CR36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/01.HYP.31.1.349","volume":"31","author":"P Gohlke","year":"1999","unstructured":"Gohlke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1999;31:349\u201355.","journal-title":"Hypertension"},{"key":"6473_CR37","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.CIR.0000128696.12245.57","volume":"109","author":"WW Batenburg","year":"2004","unstructured":"Batenburg WW, Garrelds IM, Bernasconi CC, et al. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation. 2004;109:2296\u2013301.","journal-title":"Circulation"},{"key":"6473_CR38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI7886","volume":"104","author":"Y Tsutsumi","year":"1999","unstructured":"Tsutsumi Y, Matsubara H, Masaki H, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104:925\u201335.","journal-title":"J Clin Invest"},{"key":"6473_CR39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1152\/physiolgenomics.2000.2.1.13","volume":"2","author":"M Akishita","year":"2000","unstructured":"Akishita M, Horiuchi M, Yamada H, et al. Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol Genomics. 2000;2:13\u201320.","journal-title":"Physiol Genomics."},{"key":"6473_CR40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/01.HYP.0000090323.58122.5C","volume":"42","author":"PM Abadir","year":"2003","unstructured":"Abadir PM, Carey RM, Siragy HM. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension. 2003;42:600\u20134.","journal-title":"Hypertension"},{"key":"6473_CR41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12576-012-0209-8","volume":"62","author":"R Hermann","year":"2012","unstructured":"Hermann R, Marina Prendes MG, Torresin ME, V\u00e9lez D, Savino EA, Varela A. Effects of the AMP-activated protein kinase inhibitor compound C on the postconditioned rat heart. J Physiol Sci. 2012;62:333\u201341.","journal-title":"J Physiol Sci"},{"key":"6473_CR42","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1253\/circj.CJ-10-1139","volume":"75","author":"LC Thuc","year":"2011","unstructured":"Thuc LC, Teshima Y, Takahashi N, et al. Cardioprotective effects of pravastatin against lethal ventricular arrhythmias induced by reperfusion in the rat heart. Circ J. 2011;75:1601\u20138.","journal-title":"Circ J"},{"key":"6473_CR43","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/01.HYP.0000048340.53100.43","volume":"41","author":"Y Oishi","year":"2003","unstructured":"Oishi Y, Ozono R, Yano Y, et al. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension. 2003;41:814\u20138.","journal-title":"Hypertension"},{"key":"6473_CR44","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","volume":"57","author":"JW Calvert","year":"2008","unstructured":"Calvert JW, Gundewar S, Jha S, et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes. 2008;57:696\u2013705.","journal-title":"Diabetes"},{"key":"6473_CR45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","volume":"104","author":"S Gundewar","year":"2009","unstructured":"Gundewar S, Calvert JW, Jha S, et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res. 2009;104:403\u201311.","journal-title":"Circ Res"},{"key":"6473_CR46","doi-asserted-by":"crossref","first-page":"H1086","DOI":"10.1152\/ajpheart.00959.2011","volume":"302","author":"AK Olson","year":"2012","unstructured":"Olson AK, Bouchard B, Ning XH, Isern M, Rosiers CD, Portman MA. Triodothironine increases myocardial function and pyruvate entry into the citric acid cycle after reperfusion in a model of infant cardiopulmonary bypass. Am J Physiol Heart Circ Physiol. 2012;302:H1086\u201393.","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-013-6473-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6473-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T12:34:43Z","timestamp":1746016483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-013-6473-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,27]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["6473"],"URL":"https:\/\/doi.org\/10.1007\/s10557-013-6473-x","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[2013,6,27]]}}}